Pharming Group N.V. (PHAR) Net Income by Year
Pharming Group N.V. reported $2.9M in net income in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025.
Annual figures, oldest first. Point at a bar to read its period.
PHAR Net Income by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Pharming Group N.V. financials
Frequently Asked Questions
Pharming Group N.V. reported $2.9M in net income in fiscal year 2025.
Pharming Group N.V. (PHAR) reported a $11.8M net loss in fiscal year 2024 and $2.9M in net income in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 7 fiscal years this page covers, Pharming Group N.V. (PHAR) net income went from $40.6M in fiscal year 2019 to $2.9M in fiscal year 2025.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Pharming Group N.V. (PHAR) reported on that line in every period on record.